AC
HALO icon

AlphaCore Capital’s Halozyme HALO Stock Holding History

AlphaCore Capital’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.17M Sell
40,493
-1,272
-3% -$86.7K 0.06% 246
2026
Q1 		$2.7M Buy
41,765
+254
+0.6% +$17.9K 0.06% 219
2025
Q4 		$2.79M Buy
41,511
+377
+0.9% +$25.4K 0.06% 227
2025
Q3 		$3.02M Buy
41,134
+23
+0.1% +$1.53K 0.1% 154
2025
Q2 		$2.14M Buy
41,111
+3,005
+8% +$171K 0.08% 180
2025
Q1 		$2.43M Buy
+38,106
New +$2.21M 0.21% 103

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

AlphaCore Capital's HALO Position: Q2 2026 in Review

AlphaCore Capital reduced its Halozyme (HALO) stake by 3% in Q2 2026, selling an estimated $86.7K and leaving 40,493 shares worth $3.17M. The position accounts for 0.06% of the portfolio, ranked #246.

AlphaCore Capital first reported a position in HALO in Q1 2025 and has held it in 6 quarters since. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • AlphaCore Capital held 40,493 shares of Halozyme worth $3.17M as of Q2 2026.
  • AlphaCore Capital sold 1,272 Halozyme shares in Q2 2026, an estimated $86.7K.
  • Halozyme made up 0.06% of AlphaCore Capital's portfolio in Q2 2026, its #246 holding.
  • AlphaCore Capital first reported a position in Halozyme in Q1 2025 and has held it in 6 quarters since.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on AlphaCore Capital's 13F filing for Q2 2026, filed 6 Aug 2026.